181 related articles for article (PubMed ID: 1827344)
21. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
Keating GM
Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
[TBL] [Abstract][Full Text] [Related]
22. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
[TBL] [Abstract][Full Text] [Related]
23. Topical tretinoin or adapalene in acne vulgaris: an overview.
Jain S
J Dermatolog Treat; 2004 Jul; 15(4):200-7. PubMed ID: 15764031
[TBL] [Abstract][Full Text] [Related]
24. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
25. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
Capizzi R; Landi F; Milani M; Amerio P
Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
[TBL] [Abstract][Full Text] [Related]
26. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
[TBL] [Abstract][Full Text] [Related]
27. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Egan N; Loesche MC; Baker MM
Cutis; 2001 Oct; 68(4 Suppl):20-4. PubMed ID: 11845944
[TBL] [Abstract][Full Text] [Related]
28. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
29. Adapalene 0.1% gel has low skin-irritation potential.
Verschoore M; Poncet M; Czernielewski J; Sorba V; Clucas A
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S104-9. PubMed ID: 9204086
[TBL] [Abstract][Full Text] [Related]
30. Pivotal clinical trials of adapalene in the treatment of acne.
Millikan LE
J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():19-22. PubMed ID: 11843229
[TBL] [Abstract][Full Text] [Related]
31. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
Gold LS; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
[TBL] [Abstract][Full Text] [Related]
32. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
Kakita L
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S51-4. PubMed ID: 10898831
[TBL] [Abstract][Full Text] [Related]
33. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne.
Brogden RN; Goa KE
Drugs; 1997 Mar; 53(3):511-9. PubMed ID: 9074847
[TBL] [Abstract][Full Text] [Related]
34. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
Webster GF; Guenther L; Poulin YP; Solomon BA; Loven K; Lee J
Cutis; 2002 Feb; 69(2 Suppl):4-11. PubMed ID: 12095066
[TBL] [Abstract][Full Text] [Related]
35. Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial.
Thiboutot D; Pariser DM; Egan N; Flores J; Herndon JH; Kanof NB; Kempers SE; Maddin S; Poulin YP; Wilson DC; Hwa J; Liu Y; Graeber M;
J Am Acad Dermatol; 2006 Feb; 54(2):242-50. PubMed ID: 16443054
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation.
Chalker DK; Lesher JL; Smith JG; Klauda HC; Pochi PE; Jacoby WS; Yonkosky DM; Voorhees JJ; Ellis CN; Matsuda-John S
J Am Acad Dermatol; 1987 Aug; 17(2 Pt 1):251-4. PubMed ID: 2957398
[TBL] [Abstract][Full Text] [Related]
37. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
[TBL] [Abstract][Full Text] [Related]
38. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
[TBL] [Abstract][Full Text] [Related]
39. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
Lucky A; Jorizzo JL; Rodriguez D; Jones TM; Stewart DM; Tschen EH; Kanof NB; Miller BH; Wilson DC; Loven KH
Cutis; 2001 Oct; 68(4 Suppl):34-40. PubMed ID: 11845946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
